Actavis Montelukast 10 mg film-coated tablets

Montelukast Actavis is a generic medication used primarily for the treatment and prevention of asthma and allergic rhinitis symptoms. The brand Actavis has a complex history and was originally established in Iceland as Pharmaco before evolving through several mergers to become one of the world's leading generic pharmaceutical companies.

In contemporary ownership, the Actavis brand and its portfolio were acquired by Teva Pharmaceutical Industries Ltd. in 2016 from Allergan (formerly Actavis plc). Manufacturing for these tablets typically takes place across various global sites within Teva's extensive supply chain network, depending on the specific regional market requirements. The packaging shown features German text, indicating it is intended for the DACH region, where distribution is managed by local subsidiaries of the parent company.